Back to the archive

The encyclopedia · Product & Design · Operational decision · 2025

Hema's 'antibiotic-free' eggs carried a banned drug — premium brand's quality black box

A cockroach in X-store wontons, then eggs with a banned veterinary drug 55% over the limit — regulators opened cases while Hema offered refunds.

Hema (盒马) · 2025-05-08

What happened

In February 2025, a Shanghai consumer chewing through shepherd's-purse-and-pork wontons from a Hema X member store found a whole cockroach inside; the maker was Wuxi Shangqinghe Food. Shanghai regulators filed a case and sent an assistance-investigation letter to the manufacturer, with Wuxi authorities joining in. Hema sent staff to offer a refund, was called perfunctory for trying to push responsibility onto the manufacturer, and still answered 'negotiation in progress' after regulators had stepped in. The consumer's demands for ten-times compensation and damages remained unresolved.

In May 2025 the regulatory notices stacked up. Shandong's 'you point, we inspect' sampling found that 'antibiotic-free' eggs sold by Hema contained dimetridazole — a banned veterinary drug — at 55% over the limit and trimethoprim at 30% over; the supplier claimed its own retests passed, while Hema had missed filing its re-inspection application. In Nanjing, Hema's ready-to-eat kiwifruit was found 70% over the limit for the swelling agent forchlorfenuron. The products that failed were the ones carrying premium labels — 'antibiotic-free', 'premium', 'ready-to-eat'.

The pattern put a premiumization push ahead of the quality system. Hema's answers stuck to 'verifying with the supplier' and 'handling customer complaints', with no traceability results disclosed — the same reflex as 2024, when its X member stores were repeatedly exposed selling counterfeit name-brand cosmetics and Hema offered refunds but refused triple compensation. Analysts put it bluntly: the 30-minute delivery efficiency myth had collided with a quality black box. A brand that sells trust as the product cannot outsource the proof of it to supplier reports.

Why it happened

  • Premium labels were sold faster than quality could back them: 'antibiotic-free' eggs carried a banned drug at 55% over the limit, and the supplier's self-inspection stood in for proof.
  • The response template made it worse — refunds offered, blame pushed to manufacturers, traceability undisclosed — while regulators filed cases and Hema said 'negotiation in progress.'
  • Scale-first expansion left upstream traceability unbuilt: a long-tail fresh supply chain audited through supplier reports alone is a risk system waiting for a sampling notice.
What it costRegulatory cases opened; premium persona damagedembarrassing

The lesson

Premium pricing is a quality promise. Hema sold 'antibiotic-free' eggs carrying a banned drug and wontons with a cockroach inside — refunds can't close a case that regulators have opened.

Aftermath

The structural flaw named in the ESG analysis: fresh retail's long-tail supply chain can't be controlled by supplier reports alone, and the quality system must upgrade in step with premium labels — otherwise every 'concept' product becomes a sampling target. Hema's inspection notices kept accumulating through the summer of 2025. Whether 30-minute delivery can coexist with a quality black box is the question regulators keep answering for it.

Sources

spotted an error? The club wants to know.

Comments · 0

    Sign in to join the comments.

    More like this

    Somewhere, someone solved the problem this company failed at. 2nd Opinion →